Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

2.

Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.

Yusenko MV, Kovacs G.

Histopathology. 2009 Dec;55(6):687-95. doi: 10.1111/j.1365-2559.2009.03449.x.

PMID:
20002769
3.

S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Li G, Barthelemy A, Feng G, Gentil-Perret A, Peoc'h M, Genin C, Tostain J.

Histopathology. 2007 Apr;50(5):642-7.

PMID:
17394501
4.

Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study.

Rocca PC, Brunelli M, Gobbo S, Eccher A, Bragantini E, Mina MM, Ficarra V, Zattoni F, Zamò A, Pea M, Scarpa A, Chilosi M, Menestrina F, Bonetti F, Eble JN, Martignoni G.

Mod Pathol. 2007 Jul;20(7):722-8. Epub 2007 May 4.

5.

S100A1 and KIT gene expressions in common subtypes of renal tumours.

Li G, Gentil-Perret A, Lambert C, Genin C, Tostain J.

Eur J Surg Oncol. 2005 Apr;31(3):299-303.

PMID:
15780567
6.

Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Osunkoya AO, Yin-Goen Q, Phan JH, Moffitt RA, Stokes TH, Wang MD, Young AN.

Hum Pathol. 2009 Dec;40(12):1671-8. doi: 10.1016/j.humpath.2009.05.006. Epub 2009 Aug 19.

7.

Expression of vitamin D3 receptor in kidney tumors.

Liu W, Tretiakova M, Kong J, Turkyilmaz M, Li YC, Krausz T.

Hum Pathol. 2006 Oct;37(10):1268-78. Epub 2006 Jul 27.

PMID:
16949927
8.

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, Khoo SK, Sugimura J, Fujioka T, Furge KA, Kort E, Giraud S, Ferlicot S, Vielh P, Amsellem-Ouazana D, Debré B, Flam T, Thiounn N, Zerbib M, Benoît G, Droupy S, Molinié V, Vieillefond A, Tan PH, Richard S, Teh BT.

BMC Cancer. 2010 May 12;10:196. doi: 10.1186/1471-2407-10-196.

9.

Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.

Kuroda N, Kanomata N, Yamaguchi T, Imamura Y, Ohe C, Sakaida N, Hes O, Michal M, Shuin T, Lee GH.

Med Mol Morphol. 2011 Jun;44(2):111-5. doi: 10.1007/s00795-009-0461-z. Epub 2011 Jun 30.

PMID:
21717314
10.

Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.

Rohan S, Tu JJ, Kao J, Mukherjee P, Campagne F, Zhou XK, Hyjek E, Alonso MA, Chen YT.

Clin Cancer Res. 2006 Dec 1;12(23):6937-45.

11.

High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G.

BMC Cancer. 2009 May 18;9:152. doi: 10.1186/1471-2407-9-152.

12.

Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS.

Am J Pathol. 2001 May;158(5):1639-51. Erratum in: Am J Pathol 2002 Jun;160(6):2311.

13.

C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.

Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.

Hum Pathol. 2005 Mar;36(3):262-8.

PMID:
15791570
14.

Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.

Hornsby CD, Cohen C, Amin MB, Picken MM, Lawson D, Yin-Goen Q, Young AN.

Arch Pathol Lab Med. 2007 Oct;131(10):1541-6.

PMID:
17922590
15.

Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.

Kuroda N, Inoue K, Guo L, Miyazaki E, Hayashi Y, Naruse K, Toi M, Hiroi M, Shuin T, Enzan H.

Hum Pathol. 2001 Oct;32(10):1071-7.

PMID:
11679941
16.

Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.

Gaut JP, Crimmins DL, Lockwood CM, McQuillan JJ, Ladenson JH.

Mod Pathol. 2013 May;26(5):716-24. doi: 10.1038/modpathol.2012.202. Epub 2012 Nov 30.

17.

Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.

Iribe Y, Kuroda N, Nagashima Y, Yao M, Tanaka R, Gotoda H, Kawakami F, Imamura Y, Nakamura Y, Ando M, Araki A, Matsushima J, Nakatani Y, Furuya M.

Pathol Int. 2015 Mar;65(3):126-32. doi: 10.1111/pin.12254. Epub 2015 Jan 19.

PMID:
25597876
18.

Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.

Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.

J Urol. 2009 May;181(5):2305-11. doi: 10.1016/j.juro.2009.01.003. Epub 2009 Mar 19.

PMID:
19303095
19.

Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.

Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN.

Hum Pathol. 2009 Feb;40(2):206-10. doi: 10.1016/j.humpath.2008.07.002. Epub 2008 Sep 16.

PMID:
18799195
20.

Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.

Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.

Am J Clin Pathol. 2006 Jul;126(1):79-85.

PMID:
16753598

Supplemental Content

Support Center